| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 24,819 | 21,869 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 13,616 | 7,997 |
| Cash and cash equivalents at beginning of period | 22,236 | - |
| Cash and cash equivalents at end of period | 35,852 | - |
EXAGEN INC. (XGN)
EXAGEN INC. (XGN)